Performance Evaluation of the Bio-Rad Geenius HIV1/2 Supplemental Assay

CompletedOBSERVATIONAL
Enrollment

419

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
HIV
Interventions
DEVICE

Geenius HIV1/2 Supplemental Assay

The purpose of this study is to evaluate the performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay test in finger stick whole blood, venous whole blood, serum or plasma (EDTA, heparin, sodium citrate).

Trial Locations (5)

20910

Clinical Trials Center, Walter Reed Army Institute of Research, Silver Spring

30333

Center for Disease Control and Prevention, Atlanta

94110

HIV/AIDS Division, San Fransisco General Hospital, San Francisco

94118

Blood Systems Research Institute, San Francisco

98104-2499

University Of Washington AIDS Clinical Trials Unit, Harborview Medical Center, Seattle

Sponsors
All Listed Sponsors
lead

Bio-Rad Laboratories

INDUSTRY

NCT02401555 - Performance Evaluation of the Bio-Rad Geenius HIV1/2 Supplemental Assay | Biotech Hunter | Biotech Hunter